- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05611008
Testing the SNOWDROP Intervention: Using a Clinical Decision Support System and Patient Portal for Falls Prevention Among Older Patients in Primary Care (SNOWDROP)
January 9, 2024 updated by: Julia van Weert, University of Amsterdam
Seniors Empowered Via Big Data to Joint-manage Their Medication-related Risk of Falling in Primary Care
Falls are a leading cause of injuries among older patients.
Medication use is a major risk factor for falls.
Because we lack tools to assess individualized risks, general practitioners (GPs) struggle with fall-related medication management for older patients.
Furthermore, these older patients are often not properly equipped to engage in the joint management of their medication.
A Clinical Decision Support System (CDSS) for GPs and a patient portal for older patients may stimulate shared decision making between GPs and older patients when discussing the medication-related fall risk.
The CDSS provides the GP with advice on how to alter medication in such a way that the fall risk decreases, and the patient portal helps the older patient to prepare for a consultation and to engage in the joint management of their medication.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
85
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Amsterdam, Netherlands
- Huisartsenpraktijken
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
70 years and older (Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Aged 70 years or older
- High fall risk
- Takes at least 1 Fall Risk Increasing Drug (FRID)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention condition
|
A Clinical Decision Support System (CDSS) that calculates older patients' personalized fall risk and provides the GP with advice on how to adjust the patient's medication in order to lower the fall risk.
A patient portal that provides general information on falls and fall risk to the older patients and helps the patient to prepare for the consultation by filling out a Question Prompt List (QPL).
The QPL is a list of possibly relevant questions and topics from which the patient can select those that are important to him/her.
These will already be sent to the GP before the consultation takes place.
|
|
No Intervention: Control condition
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Shared decision making
Time Frame: During consultation
|
This concerns the extent to which shared decision making between patient and GP during the consultation.
This will be assessed using the Observer OPTION Multiple Chronic Conditions (OPTION-MCC).
Consultation are audiotaped and will be coded on shared decision making using this coding scheme.
|
During consultation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Technology Acceptance Model (TAM; patient portal)
Time Frame: At baseline & two weeks after consultation
|
The Technology Acceptance Model (TAM) measures the adoption of a new technology/system based on user attitudes in relation to the patient portal.
|
At baseline & two weeks after consultation
|
|
Website Satisfaction Scale (WSS; patient portal)
Time Frame: At baseline & two weeks after consultation
|
The Website Satisfaction Scale (WSS) measures satisfaction with comprehensibility, satisfaction with attractiveness, and satisfaction with emotional support, in relation to the patient portal.
|
At baseline & two weeks after consultation
|
|
Patient portal usage
Time Frame: At baseline & two weeks after consultation
|
Patients are asked if they used the patient portal and which components they used.
|
At baseline & two weeks after consultation
|
|
Beliefs About Medicines Questionnaire (BMQ)
Time Frame: Baseline & two weeks after consultation
|
The Beliefs about Medicines Questionnaire measures beliefs about the necessity of medication and concerns about medication.
|
Baseline & two weeks after consultation
|
|
Netherlands Patient Information Recall Questionnaire (NPIRQ)
Time Frame: Two weeks after consultation
|
The Netherlands Patient Information Recall Questionnaire consists of open questions measuring patients' recall of what was discussed and decided during the consultation.
|
Two weeks after consultation
|
|
Decisional Conflict Scale (DCS)
Time Frame: Two weeks after consultation
|
The decisional conflict scale measures decisional conflict after the consultation related to five subscales: feeling informed, uncertainty, values clarity, support, and effective decision making.
|
Two weeks after consultation
|
|
Changes in medication
Time Frame: Baseline & two weeks after the consultation
|
Changes in prescriptions of the medication as reported in the electronic health record.
|
Baseline & two weeks after the consultation
|
|
Technology Acceptance Model (TAM; CDSS)
Time Frame: After the first consultation (study beginning) and after the last consultation (study completion after +/- 7 months)
|
The Technology Acceptance Model (TAM) measures the adoption of a new technology/system based on user attitudes in relation to the CDSS to be answered by the GP.
This is assessed by measuring Perceived Usefulness, Perceived Ease of Use, and Intention to use.
|
After the first consultation (study beginning) and after the last consultation (study completion after +/- 7 months)
|
|
The Website Satisfaction Scale (WSS; CDSS)
Time Frame: After the first consultation (study beginning) and after the last consultation (study completion after +/- 7 months)
|
The Website Satisfaction Scale (WSS) measures satisfaction with comprehensibility, satisfaction with attractiveness, and satisfaction with emotional support, in relation to the CDSS to be answered by the GP.
|
After the first consultation (study beginning) and after the last consultation (study completion after +/- 7 months)
|
|
Evaluation of the consultation
Time Frame: Immediately after each consultation
|
Four items to assess the consultation to be answered by the GP.
The items assess to what extent the patient was representative, their opinion on the communication during the consultation, the extent to which they are satisfied with any decisions made and the difficulty of the consultation.
|
Immediately after each consultation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Julia C.M. van Weert, Amsterdam School for Communication Research (ASCoR), University of Amsterdam
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 21, 2022
Primary Completion (Actual)
October 30, 2023
Study Completion (Actual)
October 30, 2023
Study Registration Dates
First Submitted
October 18, 2022
First Submitted That Met QC Criteria
November 3, 2022
First Posted (Actual)
November 9, 2022
Study Record Updates
Last Update Posted (Actual)
January 10, 2024
Last Update Submitted That Met QC Criteria
January 9, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 2022-PC-15274
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
Currently no plan
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Deprescribing
-
University of MichiganUniversity of SydneyCompletedDeprescribingUnited States
-
Université Catholique de LouvainEBPracticenet; Fonds National de la Recherche scientifique (FNRS)RecruitingBenzodiazepines DeprescribingBelgium
-
Wake Forest University Health SciencesCompleted
-
Monash UniversityNational University Hospital, Singapore; Guardian; NTUC Unity; Watsons; Kwong Wai... and other collaboratorsCompleted
-
Brigham and Women's HospitalNational Institute on Aging (NIA); University of Southern CaliforniaEnrolling by invitationDeprescribing | Statin PrescribingUnited States
-
Université Catholique de LouvainEBPracticenet; Fonds National de la Recherche scientifique (FNRS)RecruitingBenzodiazepine DeprescribingBelgium
-
Magi ClaveriaFundacio d'Atencio PrimariaActive, not recruiting
-
Bright Vision HospitalUnknownDeprescribing | Multi-disciplinary | RoundsSingapore
-
Nantes University HospitalFondation de France; Nantes UniversityRecruitingDeprescribing | Palliative Care | OncologyFrance
-
Centre de recherche du Centre hospitalier universitaire...RecruitingPhysical Function | Deprescribing Anticholinergic and Sedative MedicationsCanada
Clinical Trials on CDSS
-
Heidelberg UniversityKarolinska Institutet; University Ghent; Centre de Recherche en Sante de Nouna... and other collaboratorsUnknownAntenatal Care and DeliveryGermany
-
Huazhong University of Science and TechnologyNot yet recruitingRespiratory Tract Infections (RTI)China
-
Samara Regional Cardiology DispensaryMedicbook LLCCompletedAtrial Fibrillation | Arterial HypertensionRussia
-
Indiana UniversityAgency for Healthcare Research and Quality (AHRQ)CompletedSexually Transmitted Diseases | Substance Use Disorders | Depression DiagnosisUnited States
-
Beijing Tiantan HospitalNot yet recruiting
-
Taipei Medical UniversityNational Science Council, TaiwanUnknownRadiographic Contrast Agent NephropathyTaiwan
-
Brown UniversityNational Institute of Allergy and Infectious Diseases (NIAID); Moi Teaching... and other collaboratorsEnrolling by invitationPatient Engagement | Treatment Adherence | Human Immunodeficiency Virus | HIV Viremia | Treatment Compliance | Patient Dropouts | Patient No ShowKenya
-
University of California, San FranciscoCompletedHypertension | Renal Insufficiency, ChronicUnited States
-
Prof. dr. Stefan SleijferLund University; Medical University of Vienna; Landspitali University HospitalNot yet recruiting
-
Hospital Italiano de Buenos AiresDuke UniversityUnknown